Furthermore, Choi and colleagues demonstrated that Decitabine treated naive CD4+CD25− T cells from B6 mice (60% Foxp3+) were able to protect lethally irradiated BALB/c mice from GvHD when given T-cell depleted BM and conventional T cells from the same B6 mice (171). Here, CD4 is linked to graft versus host disease.